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During heart formation, the heart grows and undergoes dramatic morphogenesis to 
achieve efficient embryonic function. Both in fish and amniotes, much of the growth 
occurring after initial heart tube formation arises from second heart field (SHF)-derived 
progenitor cell addition to the arterial pole, allowing chamber formation. In zebrafish, this 
process has been extensively studied during embryonic life, but it is unclear how larval 
cardiac growth occurs beyond 3 days post-fertilisation (dpf).  By quantifying zebrafish 
myocardial growth using live imaging of GFP-labelled myocardium we show that the 
heart grows extensively between 3 and 5 dpf.  Using methods to assess cell division, 
cellular development timing assay and Kaede photoconversion, we demonstrate that 
proliferation, CM addition, and hypertrophy contribute to ventricle growth. 
Mechanistically, we show that reduction in Mef2c activity (mef2ca+/-;mef2cb-/-), 
downstream or in parallel with Nkx2.5 and upstream of Ltbp3, prevents some CM 
addition and differentiation, resulting in a significantly smaller ventricle by 3 dpf. After 3 
dpf, however, CM addition in mef2ca+/-;mef2cb-/- mutants recovers to a normal pace, 
and the heart size gap between mutants and their siblings diminishes into adulthood. 
Thus, as in mice, there is an early time window when SHF contribution to the 
myocardium is particularly sensitive to loss of Mef2c activity. 
 
Introduction  
The heart is the first functional organ to form in amniotes (Buckingham et al., 2005). The 
early heart tube is formed of cells that are specified from lateral anterior splanchnic 
mesoderm and differentiate into cardiomyocytes (CMs) following combinatorial signals 
from neighbouring tissues (reviewed in (Kelly et al., 2014). Early heart development is 
well conserved amongst model organisms in key morphogenetic processes, specific 
genes involved and subsequent growth of the heart tube. Three modes of growth can 




be utilised in myocardial growth; addition of new CMs, proliferation of existing CMs 
and/or growth of CMs themselves (hypertrophy). Work in chick and mouse using dyes, 
transgenic lines, retrospective lineage analysis and genetic tracing with Cre 
recombinase has demonstrated that addition of cells to the arterial and venous poles of 
the heart tube occurs during heart growth (Cai et al., 2003; Kelly et al., 2001; Meilhac et 
al., 2004; Meilhac et al., 2003; Mjaatvedt et al., 2001 ; Verzi et al., 2005; Waldo et al., 
2001; Zaffran et al., 2004). The progenitors of these late-added cells lie anterior to the 
heart in the pharyngeal region, referred to as the anterior or second heart field (SHF) to 
distinguish it from the first heart field, that forms the early or primitive heart tube. SHF 
cells are the main source of cells of the right ventricle and outflow tract (OFT) (reviewed 
in (Kelly et al., 2014) . Addition of SHF-derived CM progenitors is an ongoing process 
that continues for a period of three days in the mouse, throughout the time of heart tube 
elongation and cardiac looping (Moorman et al., 2007; Prall et al., 2007) and in 
equivalent stages during chick development (Abu-Issa and Kirby, 2008; Tirosh-Finkel et 
al., 2006; van den Berg et al., 2009). Similarly to CM addition, hypertrophy of CMs also 
occurs at select locations in the chick heart. Older differentiated cells in the heart tube 
undergo hypertrophy and newly added CMs are smaller in size (Soufan et al., 2006). In 
mouse, hypertrophy has been shown to occur beyond heart looping stages by 
quantifying myofibril and cell length changes (Hirschy et al., 2006). Heart growth 
continues after the formation of heart chambers, and occurs at least partially from local 
proliferation (de Boer et al., 2012). However, it is not clear when the addition of cells to 
the heart from an external source stops, and how much each growth mode contributes 
at late developmental stages.  
In zebrafish, atrial and ventricular precursor cells constituting the first heart field are 
localised at the marginal zone of the embryo at 5 hours post-fertilisation (hpf), and 
following gastrulation migrate to form bilateral heart fields, which then migrate to the 




midline and fuse to form a cardiac disc. Simultaneously, endocardial cells have formed 
and become surrounded by the myocardial precursor cells. The disc everts into a 
cardiac cone, which remodels to give a two layered, beating heart tube by one day post 
fertilisation (dpf) (Bakkers, 2011; Stainier et al., 1993; Yelon, 2001). As in amniotes, in 
both fish and frog heart tube elongation is accompanied by addition of late differentiating 
SHF-like CMs to the OFT and inflow tract (IFT) (reviewed in (Knight and Yelon, 2016). 
Ventricular growth in the zebrafish prior to 3 dpf occurs by hypertrophy (Auman et al., 
2007; Lin et al., 2012) , CM addition (de Pater et al., 2009) and CM immigration (Staudt 
et al., 2014) with little CM division (de Pater et al., 2009).  Most studies of CM 
development in zebrafish have concentrated on early development, tube formation, 
morphogenesis and looping in the first 2-3 days of development.  Investigations of later 
heart growth in zebrafish have focused on the development of trabeculation. Trabeculae 
are sponge-like muscular structures extending into the cardiac cavity, increase muscle 
mass and are important for heart function. Trabeculae form between 2 and 3 dpf and 
increase in complexity in the days thereafter (Gupta and Poss, 2012; Liu et al., 2010; 
Peshkovsky et al., 2011; Rasouli and Stainier, 2017; Samsa et al., 2015; Staudt et al., 
2014). Proliferation was shown to be essential for trabecular growth (Uribe et al., 2018). 
Whereas, some studies address growth occurring at later stages (Choi et al., 2013; 
Gupta and Poss, 2012; Hu et al., 2000; Shin et al., 2010),  crucial quantitative and 
mechanistic understanding is lacking.  
Gene networks that are involved in heart growth have been extensively characterised 
(reviewed in (Meilhac and Buckingham, 2018). Among the genes regulating SHF 
formation is the transcription factor Mef2C, a key regulator of sarcomeric myogenesis 
(reviewed by (Desjardins and Naya, 2016; Taylor and Hughes, 2017).  In the mouse, 
Mef2C expression commences at E7.5 in the cardiogenic mesoderm (Dodou et al., 
2004; Edmondson et al., 1994). Mef2C null mice die at 9.5 dpc with severe heart defects; 




the heart tube fail to undergo looping morphogenesis and only one hypoplastic ventricle 
is formed, made from a mixture of first heart field (FHF) and SHF progenitors (Bi et al., 
1999; Lin et al., 1998; Lin et al., 1997; Materna et al., 2019; Verzi et al., 2005).  In 
addition Mef2C null mice show severe vascular abnormalities and lack of smooth muscle 
differentiation (Bi et al., 1999; Lin et al., 1998; Lin et al., 1997). The mammalian Mef2C 
orthologues in zebrafish, mef2ca and mef2cb, express in the bilateral heart field and 
share overlapping functions driving CM differentiation. The double mef2ca;mef2cb 
mutant lacks most CMs and a functional heart, but has a residual differentiated CM 
population. Mef2cb is expressed strongly at the heart poles around 1 dpf and promotes 
addition of CMs to the OFT during the second dpf (Hinits et al., 2012; Lazic and Scott, 
2011). 
Here, we describe a method to quantify zebrafish myocardial growth during the 
trabeculation process. Using standardised methods to image live embryos with GFP-
labelled myocardium and to quantify the ventricle in 3D, we show that the heart grows 
extensively between 3 and 5 dpf.  CM addition, proliferation and hypertrophy contribute 
to this growth. Between 3 and 5 dpf a substantial contribution to heart growth is made 
by an nkx2.5-expressing cell population in the pharyngeal mesoderm anterior to the 
OFT. Mef2c expression is driven by Nkx2.5.  Genetic reduction of Mef2c activity 
diminishes CM addition and differentiation resulting in a smaller ventricle by 3 dpf. 
However, after 3 dpf, CM addition in Mef2c mutants recovers to a normal pace, such 
that ongoing growth gradually reduces the myocardial difference between mutants and 
their siblings. 
Materials and Methods 
Zebrafish lines, maintenance and manipulation 




Zebrafish maintenance, staging and husbandry were as previously described 
(Westerfield, 2000). Mutant and transgenic lines: Tg(myl7:EGFP)twu26 (Huang et al., 
2003), Tg(myl7:EGFP-Hsa.HRAS)s883 (D'Amico et al., 2007), Tg(–5.1myl7:DsRed2-
NLS)f2 (Mably et al., 2003),  Tg(myl7:GAL4FF)hu6531(Strate et al., 2015), 
Tg(5XUAS:RFP)zf83 (Asakawa and Kawakami, 2008), Tg(UAS:Kaede)rk8 (Hatta et al., 
2006), mef2cab1086 (Miller et al., 2007) and mef2cbfh288 (Hinits et al., 2012) were 
maintained on AB wild-type background. TgBAC(nkx2.5:GAL4FF)hu9579 and 
Tg(UAS:h2az2a-GFP)hu6851 (Strate et al., 2015)  lines were originally on TL wild type 
background. 
Genotyping of mef2cab1086 and mef2cbfh288 was performed by PCR and sequencing 
using the following primers 5’-ATTTCATGTCATGGAACTAAATCTGTT-3’ and 5’-
AAGGCCAAACTCAACAGGAACT-3’ or 5’-CATTTGGCACCCTCTGTAAGT-3’ and 5’-
ACTGAGCTGGAACTTACCTCC-3’ for b1086 allele, and for fh288 allele as described 
(Hinits et al., 2012).  
In situ hybridisation and Immunodetection 
In situ mRNA hybridization was performed as described previously (Hinits et al., 2009). 
Probes used were: mef2ca (Ticho et al., 1996),  mef2cb (IMAGE:6519749) (Hinits et al., 
2012), mef2aa (MGC:55208) (Thisse and Thisse, 2004), myl7 (Yelon et al., 1999), vmhc 
(Yelon et al., 1999),  nkx2.5 (Lee et al., 1996) and nppa (Berdougo et al., 2003). 
Embryos were photographed as wholemounts on Leica dissecting microscope (MZ16/F) 
using Olympus DP70 camera. Immunodetection was performed as previously described 
(Hinits et al., 2012).  Larvae older than 2 dpf were fixed with 2% paraformaldehyde in 
PBS for 30 minutes at room temperature. Antibodies used were against: Mef2 (c-21, 
Santa Cruz, 1:200), Mef2ca/cb (Anaspec, 1:200, (Hinits et al., 2012)), striated muscle 
myosin heavy chains (MyHC; A4.1025, 1:10 (Blagden et al., 1997), phospho-Histone 




H3 (PH3, Millipore 1: 500), Nkx2.5 (GTX128357, GeneTex, 1:50) Elastin  (Miao et al., 
2007) 1:1000), GFP (rabbit, Torrey Pines 1:500 or chicken, Abcam ab13970, 1:500) and 
RFP (rabbit PM0005, Medical and Biological Laboratories, 1:500). Alexa dye-
conjugated secondary antibodies (Invitrogen) were used at 1:1000. Hoechst 33342 
(1:1000, Thermo Fisher Scientific) stained nuclei.  Embryos/larvae were mounted in low 
melting point agarose and imaged on a Zeiss LSM Exciter confocal microscope using 
Zeiss 20x/1.0 NA dipping objective. 
EdU  treatment  
Larvae at 4 dpf were incubated with 400 µM EdU in DMSO for 24 h in fish water. After 
treatment, larvae were rinsed, anaesthetized with tricaine and fixed in 4% PFA for 1 
hour. CLICK-IT-Alexa 594 (Invitrogen) was used to label EdU according to 
manufacturer’s protocol followed by immunodetection of GFP. 
Imaging and data analysis  
To measure heartbeat, embryos lightly anaesthetised with 0.61 mM tricaine were 
observed under a Zeiss stereo microscope (Stemi SV6) and heart rate was recorded at 
1, 2 and 3 dpf. Fluorescent images were acquired on a Zeiss upright M1 stand LSM 
Exciter with a Zeiss 20X/1.0 W Plan Apochromat dipping objective using Zen software 
on larvae mounted in 1.5% low melting point agarose (LMA) in 30 mM butanedione 2-
monoxime (BDM) to prevent cardiac contractions. The heart was imaged at gradually 
increasing intervals on scan settings optimised to compromise between bleaching and 
resolution for each embryo.  
Images were processed on Volocity 6.0 software (Perkin Elmer) prior to making 
measurements by re-slicing the image stack such that the maximal extent of ventricle 
and atrium lay in a single XY plane. The central Z-slice, defined as the longest length 
and widest width of the ventricle occurring in a single Z plane (generally halfway through 




the 3D stack), was used for thickness and axis measurements. Axial growth was 
measured from the apex to the OFT (Y axis), the width of the ventricle (X axis) from the 
outer curvature towards the atrioventricular junction and the depth of the ventricle (Z 
axis) orthogonal to the central Z slice to the most ventral point of the ventricle. 
Trabecular length was measured by manual tracing of the ‘skeletal length’ of the centre 
of the myocardial wall and trabecular projections and the ‘ventricular perimeter’ in the 
central Z slice and two additional slices orthogonal to the central Z slice and each other, 
and then subtracting the summed ventricular perimeter from the skeletal length. 
Ventricular wall thickness was measured from up to 8-12 randomised points in the 
central Z slice and two orthogonal axes by measuring the length of the GFP labelled 
myocardium from outer to inner portion on the ventricular wall. The ventral half of the 
ventricle had the highest image clarity and was utilized for volume and surface area 
measurements by thresholding for GFP. Embryos with DsRed+ nuclei and cytoplasmic 
GFP were used to quantify CM number. Nuclear counts were semi automated by 
thresholding for nuclear DsRed then manually separating connected nuclei.  Graphs 
show means and standard error of the mean for the number of individual embryos 
shown.  Statistical analysis was done with SPSS (t-test or ANOVA, with Bonferroni post-
hoc tests where appropriate).  
Mosaic labelling  
For mosaic labelling, 1-2 cell Tg(myl7:EGFP-Hsa.HRAS)s883 embryos were injected with 
pCS2+_mCherry_kanR plasmid DNA (25 pg/embryo) (Bussmann and Schulte-Merker, 
2011). Embryos were imaged live at 3 and 5 dpf. 
Kaede lineage tracing 
At 3 dpf, Tg(myl7:GAL4FF)hu6531;Tg(UAS:Kaede)rk8 embryos were mounted in 1.5% low 
melting point agarose and 30 mM BDM to stop the heart for the duration of imaging. 
Prior to photoconversion, hearts were imaged using a dual 488/543 excitation and a Z-




stack collected. Immediately thereafter, a defined region in each embryo that included 
all heart Kaede-green-marked cells and their vicinity was photoconverted to Kaede-red 
by manual focusing throughout the Z-stack under continuous laser scanning using a 405 
nm laser (Hatta et al., 2006)  while assessing visually for residual green fluorescence.  
Embryos were re-scanned under dual excitation 488/543 nm post-photoconversion, 
then released from agarose and recovered in system water in the dark until 5 dpf when 
they were embedded and imaged again. Only larvae that were healthy after recovering 
were used for analysis. Photoconversion and imaging was undertaken on a Zeiss LSM 
Exciter confocal with a Zeiss W Plan-Apochromat 20X/1.0 DIC (UV) VIS-IR objective. 
Adult fish measurements 
Adult fish, reared in tanks together, were anaesthetized with tricaine, blotted dry, and 
weighed, standard length measured with a ruler nose-to-base of tail fin and fin-clipped 
for genotyping. Standard weight (K) was calculated using Fulton’s formula K = weight 
(g) x 100 x length-3 (cm)(reviewed in (Jones, 1999). A separate lay of fish were 
measured as above, followed by dissection of the heart. Hearts were imaged and 
ventricle length measured as described (Singleman and Holtzman, 2012). 
Results 
Extensive growth of the ventricle between 3 and 5 dpf 
To quantify the growth of the zebrafish ventricle between 3 and 5 dpf, hearts of 
Tg(myl7:egfp)twu26 embryos were imaged live on a confocal microscope. Ventricular 
length, from the apex to the OFT, increased by 18% between 3 and 5 dpf, from 144 ± 6 
µm to 170 ± 4 µm (p=0.002) (Fig. 1A). Thickness of the myocardial wall increased by 
35% from 5.91 ± 0.32 µm at 3 dpf to 7.99 ± 0.46 µm at 5 dpf (p=0.001; Fig. 1B).  To 
quantify the growth of the myocardium further, the GFP signal was thresholded and 
ventricular myocardial wall volume (referred to as ‘myocardial volume’ throughout the 




manuscript) and surface area measured using Volocity software (see Materials and 
Methods). Ventricular volume increased by 51% from 115,000 ± 6000 µm3 to 174,000 ± 
15,000 µm3 from 3 to 5 dpf (p=0.002, Fig. 1C), whilst surface area increased by 57% 
from 94,000 ± 8000 µm2 to 144,000 ± 9200 µm2 (p=0.0006, Fig. 1D). To determine the 
contribution of trabeculation to this myocardial growth, we estimated trabecular length 
by subtracting perimeter from the skeletal length in the central slice of the ventricle (Fig. 
1E). Trabeculae increased five-fold from 30 ± 8 µm to 196 ± 33 µm between 3 and 5 dpf 
(p=0.0001; Fig. 1E). Taken together, the data show that growth in ventricular 
myocardium size comprises increase in overall ventricle dimensions and in 
trabeculation. We next counted ventricular CM nuclei in Tg(myl7:egfp)twu26;Tg(–
5.1myl7:DsRed2-NLS)f2 embryos and observed an increase of 26% between 3 and 
5 dpf, from 193 ± 16 to 244 ± 11 nuclei (p = 0.048; Fig. 1F). As CMs are close-packed 
and increase in number by 26% but myocardial volume increases by 51%, we calculated 
average volume per CM for each larva by dividing the volume by CM number from Fig. 
1C and F.  This revealed a 17% increase from 1200 µm3 at 3 dpf to 1400 µm3 at 5 dpf. 
We mosaically-labelled CMs by injecting the pCS2+_mCherry_kanR plasmid DNA, 
expressing cytoplasmic mCherry under CMV promoter, into Tg(myl7:EGFP-
Hsa.HRAS)s883 embryos, in which myocardial cell membranes are labelled with EGFP 
(D'Amico et al., 2007) (Fig. 1G). At 3 dpf, average CM volume was 929 ± 152 µm3 (n=9) 
and rose to 1214 ± 190 µm3 (n=10) at 5 dpf, a 30% increase (Fig. 1H). Both methods 
suggest CM hypertrophy is occurring, although with some cell-to-cell heterogeneity. To 
assess hypertrophy using another independent method, we measured CM perimeter at 
3 and 5 dpf from optical sections of larval hearts of Tg(myl7:EGFP-Hsa.HRAS)s883. We 
observed an increase of 41% in CM perimeter from 31 ± 15 µm at 3 dpf to 43 ± 17 µm 
(p = 0.027; Fig. 1I,J). In conclusion, these various independent methods point to a 
contribution of CM hypertrophy to myocardial growth between 3 and 5 dpf. Taken 




together, the data show that ventricle growth results from increase in both CM number 
and size. 
 
Cardiomyocyte increase between 3 and 5 dpf arises from both division and 
addition of progenitors from outside the heart 
CM number could increase either due to CM division or addition of cells from an external 
source. To assess CM proliferation, embryos with myocardium positive for both nuclear 
GFP and cytoplasmic RFP expression, 
Tg(myl7:GAL4FF)hu6531;Tg(5XUAS:RFP)zf83;Tg(UAS:h2az2a-GFP)hu6851, were fixed at 
3, 4 or 5 dpf and immunostained for the M-phase cell cycle marker phospho-Histone H3 
(PH3, Fig. 2A)(Wang and Higgins, 2013).We found little evidence for proliferation in the 
ventricle at these stages with this method; no ventricles were observed with more than 
one PH3+ CM and several ventricles had no PH3+ CMs (Fig. 2B), similar to a previous 
study (Uribe et al., 2018). We therefore used incorporation of 5-ethynyl-2'-deoxyuridine 
(EdU) to detect DNA synthesis during S phase (Fig. 2C)(Salic and Mitchison, 2008). We 
incubated Tg(myl7:GAL4FF)hu6531;Tg(UAS:h2az2a-GFP)hu6851 embryos with EdU for 24 
h from 4 dpf to 5 dpf and found that around 5% of ventricular CMs were EdU+ (Fig. 2D). 
Similar proliferation levels were also found in atrial CMs (Fig. 2D). Thus, proliferation 
contributes to larval CM increase, as previously reported (Uribe et al., 2018), but 
appears insufficient to explain the 26% increase between 3 and 5 dpf.   
Another explanation for increase in CM number is addition of CMs from an external 
source, as occurs before 2 dpf (de Pater et al., 2009; Hami et al., 2011; Lazic and Scott, 
2011; Zhou et al., 2011), , and was shown to derive primarily from Nkx2.5+ progenitor 
population (Colombo et al., 2018; Guner-Ataman et al., 2013; Paffett-Lugassy et al., 
2017; Zhou et al., 2011).   When TgBAC(nkx2.5:GAL4FF)hu9579;Tg(UAS:h2az2a-
GFP)hu6851 fish were crossed to Tg(–5.1myl7:DsRed2-NLS)f2, some nuclei in the OFT at 




3 and 5 dpf were labelled with both markers (GFP+;DsRed+), indicating that they are 
differentiated CMs.  In addition, a population of GFP+;DsRed- nuclei, expressing nkx2.5 
but not myl7 were observed just anterior to the OFT region and numbered 50-60 cells 
at 3 dpf and ~40 cells at 5 dpf (Fig. 2E,F). These GFP+;DsRed- nkx2.5-expressing cells 
were positioned where, at earlier times, cells were shown to contribute to myocardial 
and non-myocardial cells in the OFT, as well as to pharyngeal cells (Colombo et al., 
2018; Guner-Ataman et al., 2013; Paffett-Lugassy et al., 2017; Zhou et al., 2011).  These 
data suggest that nkx2.5-expressing cells anterior to the heart provide an external 
source of CM increase between 3 and 5 dpf. 
To test whether CMs are added to the OFT from the pharyngeal region after 3 dpf, we 
used a developmental timing assay shown to work at earlier stages of development (de 
Pater et al., 2009)  employing embryos carrying myl7-driven transgenes expressing both 
EGFP and nucDsRed (de Pater et al., 2009). As fluorescence of nucDsRed protein 
takes approximately 24 hours longer than EGFP to mature, recently-formed CMs are 
EGFP+nucDsRed-, whereas older CMs are EGFP+nucDsRed+. At 3.5 dpf, many CMs in 
the OFT were EGFP+nucDsRed- (Fig. 2G-G’) indicating recent addition.  By 6 dpf, all 
CMs in the OFT region were EGFP+nucDsRed+ (Fig. 2H, H’).  These findings suggest 
that addition of CMs to the OFT had ceased prior to ~5 dpf. To test this idea further, 
photoconversion of the fluorescent protein Kaede from green to red (Ando et al., 2002). 
was employed to examine the timing of CM addition to the heart.  Green Kaede cells in 
the hearts of Tg(myl7:GAL4FF)hu6531;Tg(UAS:kaede)rk8 larvae were converted to red 
Kaede using 405 nm laser at 3 dpf (Figs 2I and S1). Subsequently, at 5 dpf, 4/4 
converted embryos had re-appearance of cells expressing only green Kaede at the 
arterial pole and in the adjacent anterior ventricle (Fig. 2I,J, J’).  Some CMs expressing 
predominantly green Kaede were also observed at the apex of the ventricle and near 
the atrioventricular canal (AVC) (Fig. 2G,H). The combined data show that addition of 




CMs from outside the arterial pole continues beyond 3 dpf, contributing to the growth of 
the ventricle and OFT together with proliferation and hypertrophy of existing CMs.  
Mef2cb is required for normal ventricle size  
We have previously shown that lack of Mef2ca and Mef2cb, the zebrafish orthologues 
of mammalian Mef2C, results in severe lack of CM differentiation and the formation of 
an abnormal string-like non-functional heart at 2 dpf (Hinits et al., 2012). In situ mRNA 
hybridisation (ISH) of embryos from incrosses of mef2ca+/-;mef2cb+/- fish showed severe 
reduction of myocardial differentiation markers in the double homozygous mutants. 
Between 22 somite stage (22 ss) and 24 hpf, myl7 expression was grossly 
downregulated in the fraction (6.25%) predicted for double mutants (6/85 = 7%) (Figs 
3A and S2A). Sequencing of genomic DNA from these embryos showed that 5/5 
embryos with a string-like heart were indeed mef2ca-/-;mef2cb-/- mutant embryos.  
Similar results were found for CM markers bmp4 (5/88 = 5.7%) and vmhc/myl7 (3/86 = 
3.5%) (Fig. S2A-C). Samples of each were confirmed as mef2ca-/-;mef2cb-/- mutants by 
sequencing.  
To test whether Mef2c genes continue to control CM addition occurring between 3 and 
5 dpf, we examined embryos from the dual heterozygote incross at later stages.  
mef2ca-/-;mef2cb-/- double mutants had a string-like beating heart, which appeared to 
grow between 3 and 5 dpf (Fig. 3B). However, double mutant embryos did not survive 
beyond 7-10 dpf.  In addition to the severe double mutant phenotype, a further fraction 
of embryos from the dual heterozygote incrosses had milder but significant defects in 
heart tube size at the linear heart tube stage: 15/85 (17.6%, myl7), 19/88 (21.6%, bmp4) 
and 25/86 (29%, vmhc/myl7)(Figs 3A and S2A-C). Most, but not all (4/5), mef2ca+/-
;mef2cb-/- embryos had hearts with clearly reduced myl7 mRNA and an abnormal shape 
(Fig. 3A). Some mef2ca-/-;mef2cb+/- embryos (2/4) were also found to have less signal 
(data not shown), but others did not (2/4, Fig. 3A). Other genotyped embryos with normal 




size heart tubes were all from other genotypes with at least two wild type alleles of 
mef2ca and/or mef2cb (10/10, Fig. 3A and data not shown).  Thus, having only a single 
wild type allele of either mef2ca or mef2cb was insufficient to prevent reduction in heart 
size at heart tube stage.  
All mef2ca homozygous mutant embryos develop a jaw phenotype and die from lack of 
feeding (Hinits and Hughes, 2007; Miller et al., 2007; Nichols et al., 2016),  whereas 
mef2ca+/-mef2cb-/- fish survive without any apparent jaw defects, allowing further study 
of heart growth and function.  Despite their frequently abnormal size and shape, hearts 
of mef2ca+/-mef2cb-/- had no difference in heart rate compared with their siblings 
between 1-3 dpf (Fig. 3C).  By 52 hpf, the heart tube had grown and underwent 
morphogenesis into the expanded chambers stage in which the ventricle is kidney 
shaped, with distinctive outer and inner curvatures (OC and IC) (Auman et al., 2007). At 
this stage, nppa mRNA accumulates in the OC, but is absent from the IC and the 
atrioventricular canal (AVC; Fig. 3D).  ISH for nppa on embryos from a cross of mef2ca+/-
;mef2cb+/- with mef2cb-/- showed that mef2ca+/-;mef2cb-/- embryos had a small, rounded 
and misshapen ventricle without the typical unstained gap between the atrium and the 
ventricle, where the IC and the AVC lie (4/5, Fig. 3D). All other genotypes showed 
normal heart shape and nppa mRNA (14/14, Fig. 3D and data not shown). Thus, 
mef2ca+/-;mef2cb-/- mutant ventricles show a morphological defect at the chamber 
expansion stage. 
To quantify changes in ventricular size of larvae with reduced Mef2c, we analysed 
cardiac growth parameters at 3 and 5 dpf for all genotypes carrying at least one wild 
type allele of mef2ca or mef2cb (Fig. 4).  At 3 dpf, mef2ca+/-;mef2cb-/- mutants had 
significantly reduced ventricular myocardial volume by 47% to 58,485 ± 7525 µm3 
(mean ± SEM) compared to 124,177 ± 8660 µm3 in siblings (a pool of all other embryos 
with two or more wild type alleles)(p=0.002, Fig. 4A,B). Ventricular width was 22% lower 




in mef2ca+/-;mef2cb-/- mutants (65 ± 6 µm) compared with siblings 
(87 ± 3 µm)(p = 0.005, Fig.4B), whereas ventricle length was unaltered (data not 
shown), implying that elongation was successful but a defect in ballooning was present.  
Trabecular length was not significantly different between mef2ca+/-;mef2cb-/- mutants 
and siblings (Fig. 4B).  In addition, measuring total ventricular wall volume of fixed 3 dpf 
myl7:EGFP fish (also stained for MyHC) showed that average ventricle volume of 
mef2ca+/-;mef2cb-/- fish is significantly smaller (by 42%) than that of their siblings 
mef2ca+/+;mef2cb+/- (Fig. S2D,E).  At 5 dpf, mef2ca+/-;mef2cb-/- ventricles had increased 
in volume but remained 35% smaller than siblings’ ventricle, 105,255 ± 13,443 µm3 
compared with 163,226 ± 10.017 µm3 (p = 0.013, Fig. 4A,B). The mef2ca+/-;mef2cb-/- 
ventricle is also significantly smaller than that of mef2cb-/- (161,167 ± 9913 µm3) 
(p = 0.03, Fig. 4A,B).  The other genotype possessing a single wild type allele, mef2ca-
/-;mef2cb+/-, showed no defect in ventricular size for any parameter at either 3 or 5 dpf 
(Fig. 4A,C). Taken together, the data show that a single wild type allele of mef2cb is 
sufficient for achieving correct ventricular size by 3 dpf, whereas one wild type allele of 
mef2ca alone fails to support normal ventricle formation on a mef2cb mutant 
background.  
CM addition in mef2ca+/-mef2cb-/- embryos is defective before 3 dpf, but normal 
thereafter 
To test the hypothesis that reduced levels of Mef2c lead to a smaller ventricle by 
reduction in the number of CMs that differentiate, ventricular CMs were counted in 
mutant and sibling embryos/larvae at 1, 3 and 5 dpf.  At 1 dpf, mef2ca+/-;mef2cb-/- 
mutants had 78 ± 16 nuclei (n=4) in the whole heart tube compared to 121 ± 8 nuclei in 
siblings (n=16), a reduction of around 43 CMs (35%) compared to wild type (p = 0.035, 
Fig. 5A,B).  At 3 dpf, mef2ca+/-;mef2cb-/- mutants may have gained a few nuclei, having 
86 ± 3 ventricular nuclei (n=4), but numbers remained low compared with 149 ± 7 




ventricular nuclei in siblings (n= 7), such that the deficit in mef2ca+/-;mef2cb-/- mutants 
had widened to ~63 (43%) fewer ventricular CMs (p = 6 x 10-5, Fig. 5B). In striking 
contrast, by 5 dpf mef2ca+/-mef2cb-/- mutants had gained many CM nuclei, reaching a 
total of 167 ± 18 (n=3) compared with siblings, which had 231 ± 13 nuclei (n=12; 
p = 0.042), only a 28% deficit. Although mutants still lagged behind their siblings at 
5 dpf, the deficit in ventricular CM number in mef2ca+/-;mef2cb-/- larvae remained 
numerically similar to that at 3 dpf at around 64 CMs fewer than siblings. In both mutants 
and siblings the number of ventricular CMs increased by around 82 during the 3 to 5 dpf 
period, suggesting CM addition was normal in mutants over this period.  Thus, the early 
defect in embryonic CM addition in mef2ca+/-;mef2cb-/- mutants recovers to a normal 
pace in the larval heart. 
 
Mef2ca and mef2cb function upstream of ltbp3 and downstream of nkx2.5 in CM 
precursors of the arterial pole 
Previous work has shown that disruption of CM progenitor cells in the SHF leads to 
smaller ventricle size at 2-3 dpf (de Pater et al., 2009; Guner-Ataman et al., 2013; Witzel 
et al., 2017; Zhou et al., 2011). To determine if reduction of Mef2c activity also affected 
the progenitor pool, we used the SHF marker ltbp3.  Ltbp3, which encodes a protein that 
modulates TGF-ß signalling, marks CM progenitor cells at the OFT (Zhou et al., 2011).  
Ltbp3 is required to generate arterial pole CM progenitors that are added to the ventricle 
and OFT before 72 hpf and knockdown of ltbp3 results in a smaller ventricle but normal 
atrium by 72 hpf (Zhou et al., 2011), reminiscent of the mef2ca+/-;mef2cb-/- phenotype.  
Expression of ltbp3 overlaps with mef2cb expression during heart tube stages and 
partially overlaps with myl7 expression (Witzel et al., 2017; Zeng and Yelon, 2014; Zhou 
et al., 2011).  Indeed, mef2ca+/-;mef2cb-/- embryos had reduced ltbp3 mRNA at 28 hpf, 
showing the progenitor pool is affected by reduction of Mef2cs (Fig. 5C), suggesting 




Mef2c regulates ltbp3 mRNA levels. Double labelling with myl7:EGFP showed reduced 
ltbp3 mRNA staining outside the heart tube. Moreover, there is also less overlap 
between myl7 and ltbp3 marked regions suggesting reduction in recently differentiated 
CMs (Fig.5C), consistent with reduced CM number seen in the heart tube (Fig. 5A).  By 
3 dpf, no obvious reduction in ltbp3 was detected near the heart OFT (Fig. 5D), a result 
that correlated with the recovery of CM addition to the arterial pole. Taken together, the 
data suggest that the early defect in CM addition to the ventricle in Mef2c-deficient 
embryos is at least partly due to Mef2c regulation of ltbp3 expression in CM progenitors 
at the arterial pole of the heart tube.  
As we show for Mef2c, nkx2.5 (together with nkx2.7) functions upstream of ltbp3 to drive 
cardiomyogenesis in the arterial pole SHF (Guner-Ataman et al., 2013; Targoff et al., 
2013). Bioinformatic analysis of the ltbp3 proximal promoter reveals multiple potential 
binding sites for Mef2c and one for Nkx2.5 (TRANSFAC, Fig. S4A).  Nkx2.5 and Nkx2.7 
were also shown to promote expression of mef2cb (Colombo et al., 2018). Comparative 
genome analysis reveals two evolutionary conserved regions (ECR) in the mef2cb locus 
that had 70-75% identity with mouse and human, both containing Nkx2.5 binding sites 
(Fig. S4B). It is possible, therefore, that Nkx2.5/Nkx2.7 regulate ltbp3 either directly or 
through Mef2c. Alternatively, Mef2c could regulate ltbp3 via effects on nkx2.5 and/or 
nkx2.7 genes, because we have previously shown that nkx2.5 mRNA is diminished in 
non-differentiating CMs in mef2ca;mef2cb double mutants (Hinits et al., 2012).   To 
distinguish between these possibilities, we examined nkx2.5 mRNA in mef2ca+/-;mef2cb-
/- mutants.  At 28 hpf, despite reduced myl7 mRNA accumulation in mef2ca+/-;mef2cb-/- 
mutants, we could not detect changes in nkx2.5 expression compared with other 
genotypes with more Mef2c (Fig. 5E).  However, by 52 hpf nkx2.5 mRNA appeared to 
be upregulated in the ventricles of mef2ca+/-;mef2cb-/- embryos (Fig. 5F; 5/7 genotyped 
embryos; 0/12 controls showed similar upregulation). Raised nkx2.5 mRNA levels were 




detected only in newly differentiated CMs at the arterial pole and the AVC in controls, 
and no nkx2.5 expression was observed outside the OFT (Fig. 5F). Using anti-Nkx2.5 
antibody, we found that the upregulation in the ventricular CMs is detected already at 
28 hpf (Fig. 5G), and it is noted in precursors in the arterial pole that are positive for 
Nkx2.5 but are negative for myl7:EGFP or show only weak myl7:EGFP (Fig. 5G). Thus, 
depleted Mef2c seem to upregulate Nkx2.5 levels in myocardial precursors. At 2-3 dpf, 
no nkx2.5 mRNA or protein is detected outside the heart (Fig. 5F, S3A).  Similar results 
were obtained using a Tg(nkx2.5:ZsYellow) line, in which neither mRNA for nkx2.5 nor 
ZsYellow was observed in precursor cells outside the OFT at 72 hpf (Paffett-Lugassy et 
al., 2017). We therefore tested whether the Nkx2.5 transgene GFP+ cells near the OFT 
(Fig. 2E), which indicate previous Nkx2.5 expression, were altered in Mef2c deficient 
embryos. To do so we crossed mef2ca+/-;mef2cb+/-
;TgBAC(nkx2.5:GAL4FF)hu9579;Tg(UAS:h2az2a-GFP)hu6851)  to mef2cb-/-.  No mef2ca+/- 
fish expressed the reporter, suggesting close linkage of the integration site of one of the 
transgenes to the mef2ca locus on chromosome 10 and thus preventing further analysis.  
In contrast, mef2cb-/- embryos did not have significantly more GFP+ precursors outside 
the OFT (Fig. S3B,C). Thus, in summary, Mef2cs act either in parallel with, or 
downstream of, nkx2.5 and both genes act upstream of ltbp3 in driving the addition and 
differentiation of ventricular CMs from the arterial pole. In addition, Nkx2.5 is upregulated 
(or fails to be downregulated) in ventricular CMs as well as in their precursors when 
Mef2cs are depleted. 
The recovery of CM addition after 3 dpf may reflect a change in the dependency of CM 
differentiation from Mef2ca/Mef2cb to other Mef2s. (Fig. S5). Mef2ca and mef2cb are 
expressed early in the heart tube, and mef2cb mRNA is abundant in the cells 
differentiating and entering the OFT region until about 2 dpf but, by 3 dpf, mef2ca and 
mef2cb mRNAs were downregulated near the heart ((Colombo et al., 2018; Hinits et al., 




2012; Lazic and Scott, 2011)  and Fig. S5A-C).  At 3 dpf, the dominant Mef2 mRNA 
detected was that from mef2aa that expresses strongly in the heart, including in the 
differentiating precursors at the arterial pole (Fig. S5A-C).  
 
Adult mef2ca+/-;mef2cb-/- are viable but smaller than siblings 
Despite the apparent return to a normal pace of CM addition from 3 to 5 dpf, ventricle 
size at 5 dpf is still significantly reduced in mef2ca+/-;mef2cb-/- mutants (Fig. 4). To 
investigate whether this defect affected further development and survival of mef2ca+/-
;mef2cb-/- mutants into adulthood, two separate crosses producing mef2ca+/-;mef2cb-/- 
embryos were reared to adulthood. mef2ca+/-;mef2cb-/- mutants were viable and fertile 
as adults. Genotyped crosses that were analysed at 3-4 months of age yielded the 
expected numbers of progeny of each genotype, with the exception of total absence of 
double mutants.  In a cross between mef2ca+/-;mef2cb+/- and mef2ca+/+;mef2cb-/-, 25/82 
(30%) were found to be mef2ca+/-;mef2cb-/- (χ2=0.251) and in a cross between mef2ca+/-
;mef2cb+/- and mef2ca+/+;mef2cb+/-, 6/51 (12.5%) were found to be mef2ca+/-;mef2cb-/- 
(χ2 = 0.874). We measured two lays of adult fish around 3-4 months for length and 
weight.  Interestingly, mef2ca+/-;mef2cb-/- mutants are significantly smaller in both weight 
and length compared with their siblings (Fig. 6A), although standard weight (SW), which 
compensates for length change (SW = weight (g) x 100 /[length (cm)]3) was not 
significantly different (Fig. 6A). To test whether the reduction of Mef2c had affected the 
heart, we dissected hearts from 4 month old fish and measured ventricular length (VL), 
which did not differ significantly between mef2ca+/-;mef2cb-/- mutant and sibling hearts 
(Fig. 6B,C). In juvenile and adult zebrafish, VL is correlated to standard length (SL) and 
VL/SL averages around 4.3% (varies between 2.7-7.8%) throughout life (Singleman and 
Holtzman, 2012).  Despite all mef2ca+/-;mef2cb-/- mutants remaining below the trend line 
(Fig. 6D), all Mef2c genotypes tested had a VL/SL figure within the normal range 




between 3.3% and 4.8% (Fig. 6D).  Thus, despite the embryonic CM deficit and size 
difference, mef2ca+/-;mef2cb-/- mutants are viable and have functional hearts of normal 
size as adults.  
 
Discussion 
The findings of this work demonstrate three major points.  Firstly, we show that the 
developing heart grows beyond 3 dpf by significant increase in ventricular myocardial 
volume, primarily due to trabeculation and outward expansion. The growth is achieved 
by both proliferation of existing CMs and addition of CMs from a pool of precursors from 
3 to 5 dpf, along with cellular hypertrophy of individual CMs. Secondly, we show that 
normal ventricular growth prior to 3 dpf requires a threshold level of Mef2c, and this 
threshold diminishes after 3 dpf.  Thirdly, adult mef2ca+/-;mef2cb-/- fish with significantly 
smaller heart at 3 dpf survive to adulthood but are smaller than their siblings.  
 
Modes of growth of the ventricular myocardium after cardiac looping 
We investigated cellular mechanisms (modes) contributing to the cardiac growth 
observed between 3 and 5 dpf. The myocardial wall of the heart tube could balloon 
outwards during chamber formation (Auman et al., 2007; Christoffels et al., 2000; 
Moorman and Christoffels, 2003), leading to outward growth accompanied by 
myocardial thinning. Alternatively, the myocardial wall could thicken, either by 
hypertrophy or cell division.  In addition, trabeculation, by repositioning CMs, gives 
inward growth into the lumen of the ventricle (Liu et al., 2010; Peshkovsky et al., 2011; 
Staudt et al., 2014), and could thus thin the myocardial wall between trabeculae. A 
combination of these growth modes must be occurring between 3 and 5 dpf. Our data 
suggest around 5% of existing CMs in both chambers pass through S phase between 4 
and 5 dpf, consistent with work using a FUCCI (fluorescent ubiquitylation-based cell 




cycle indicator) system (Choi et al., 2013) . Choi et al. observed 4-5% CMs in S/G2/M 
phases between 3-5 dpf in the whole heart. These findings contrast with another study 
using a slightly different FUCCI system, which showed around 14% of CMs expressing 
Tg(myl7:mVenus-gmnn) and 9% of CMs labelled by 6 h of EdU at 5 dpf, and suggested 
proliferation is the main contributor to CM number increase between 3 and 5 dpf (Uribe 
et al., 2018). Like Uribe et al, we also examined M-phase CMs with PH3 and observed 
low numbers of 0 or 1 PH3+ CMs per embryo.  Low CM proliferation rates were also 
found by using PH3 and BrdU at 24-48 hpf (de Pater et al., 2009).  Assuming that among 
the approximately 200 CMs present at 3 dpf, one (0.5%) is in an M-phase lasting 15 
minutes (a typical value in many eukaryotic cells) and 10-28 (5-14%) are in S/G2/M, 
then S/G2/M must last between 3-9 h, a range congruent with the 7-8 h estimate from 
time lapse imaging by Uribe et al. (2018).  Labelling of 5-10% of CMs after 6 h in EdU, 
as observed by Uribe et al., thus suggests that ~30% of CMs undergo mitosis per day, 
which would lead to a larger increase in CMs (138) than that observed. In another 
experimental series, Uribe et al. observed 15% of CMs labelled by EdU in 24 h, again 
predicting a larger increase in CMs (64) than we observed. In contrast, we only observed 
about 5% of CMs (i.e. 10) in S phase over 24 h of EdU labelling, suggesting that no 
more than 10 cells undergo mitosis per day, insufficient to account for the 50 CMs added 
between 3 and 5 dpf. Definitive resolution of this issue will require sustained high-
resolution time-lapse imaging to track and quantify CM increase. Nevertheless, our 
results suggest that proliferation cannot account for all the growth observed.  
We find that CM progenitor cells are present in a continued CM progenitor field at the 
arterial pole beyond 2 dpf and contribute to myocardial growth. CMs also undergo 
hypertorphy, such that the myocardial wall thickens, despite ballooning and 
trabeculation.  Thus, the modes of growth occurring during the well-investigated 1-2 dpf 
period (de Pater et al., 2009; Gessert and Kühl, 2009; Hami et al., 2011; Lazic and Scott, 




2011; Zhou et al., 2011) persist until 5 dpf. However, by 5 dpf, either the extra-cardiac 
progenitor pool is depleted or changes by losing expression of its known markers. 
Interestingly, our Kaede experiments show a few myocardial regions with newly-made 
Kaede-Green only CMs.  Although these areas could theoretically reflect mosaic clonal 
activation of a previously silent UAS:Kaede reporter leading to patches of green-only 
cells, we believe this unlikely for three reasons. First, transgene mosaicism is generally 
thought to be the result of position effect variegation, which is not expected to alter 
synchronously and reproducibly in local groups of cells.  Second, we do not observe an 
obvious increase in overall CM labelling, as would be expected if the reporter gradually 
became active as the heart developed. Third, we found no evidence for differential 
turnover of kaede in these cells. We prefer the simpler interpretation that green-only 
cells are newly-differentiated CMs.  In the case of the arterial pole area this may reflect 
the addition of CMs from an external pool, as suggested also by the concentration of 
newly-differentiated CMs in this region at 3.5 dpf in the developmental timing assay. 
Other areas like the AVC and the apex of the ventricle could be hotspots for proliferation 
as proliferation would dilute the converted protein overtime, and support the clonal 
distribution of cardiomyocytes seen in young juveniles (Gupta and Poss, 2012). 
Interestingly, the apex of the ventricle is where in similar developmental stages in the 
mouse (E12 and later) some SHF myocardial cells contribute to the ventricular septum 
as seen by the Mef2c-AHF-Cre fate map (Verzi et al., 2005).  
The main possible source for cells added to the arterial pole after 3 dpf is the group of 
cells outside the OFT that have previously expressed nkx2.5, isl1 and/or isl2a/2b, which 
at 3 dpf are only marked by retained fluorescent protein expression of transgenes.  
Lineage tracing of nearby cells after 3 dpf is required to determine the extent and source 
of the external pool of cells yielding new CMs in larval life.  
 





Mef2cs are required for CM addition  
Redundant roles have been suggested for different Mef2 factors across several tissues 
in various organisms (Arnold et al., 2007; Assali et al., 2019; Desjardins and Naya, 2016; 
Hinits and Hughes, 2007; Hinits et al., 2012; Lin et al., 1997; Potthoff et al., 2007; 
Sacilotto et al., 2016).  Due to genome duplication in teleosts, there are two Mef2c 
factors in the zebrafish. Our results show a clear difference in the requirement for 
Mef2ca and Mef2cb function.  While normal levels of Mef2ca can be sufficient for normal 
heart development (this work and (Hinits et al., 2012)) a single wild type allele of mef2ca 
is insufficient to support myocardial growth in the absence of Mef2cb. However, a single 
allele of mef2cb in mef2ca-/-mef2cb+/- mutants permits ventricular growth 
indistinguishable from wild type.  Mef2ca and mef2cb are both expressed early in each 
heart field and in the heart tube, but mef2cb mRNA alone is abundant in cells 
differentiating and entering the OFT region around 48 hpf. Taken together, these 
findings suggest that the function of both proteins is similar and the difference in 
functional requirement stems from their different expression patterns.  In mice there is 
only a single Mef2c gene, but early development of the heart tube occurs in Mef2c null 
mutants, possibly aided by a compensatory mechanism in which Mef2b mRNA is 
upregulated 7-fold (Lin et al., 1997).  In contrast, later SHF development is severely 
affected by lack of Mef2c (Lin et al., 1997; Vong et al., 2005).  Interestingly, although we 
observe a similar reduction in cardiomyogenesis from 1-3 dpf in mutants with low Mef2c 
activity, our data show that mef2ca+/-;mef2cb-/- mutants recover and add the same 
number of CMs between 3 and 5 dpf as their siblings. A major difference from mice is 
that zebrafish entirely lacking a heart can develop well for many days, whereas mice 
that are unable to build a functional four-chambered heart die from anoxia (Bi et al., 
1999; Lin et al., 1998; Lin et al., 1997; Materna et al., 2019).    Our finding of an early 




time window when SHF contribution to the myocardium is more sensitive to loss of 
Mef2c activity than either earlier or later cardiomyogenesis thus appears similar to the 
murine data available.  We hypothesise the mef2aa activity may rescue myocardial 
growth post-embryonically in the zebrafish. 
 
Effects of embryonic defects in later life 
We observe reduced size of adult mef2ca+/-mef2cb-/- fish.  Could the substantial defects 
in myocardium of 3 dpf mef2ca+/-mef2cb-/- mutants account for the adult size reduction? 
We think it possible but unlikely that the loss of just fifty early CMs has a lifelong effect, 
at least under aquarium conditions. As mef2ca and mef2cb are expressed in zebrafish 
skeletal muscle (Hinits and Hughes, 2007; Yogev et al., 2013), one attractive possibility 
is that the smaller body size is due to reduced growth in skeletal muscle. Mice with a 
skeletal muscle conditional knockout for Mef2c have reduced body weight from around 
postnatal day 10 into adulthood along with fibre type disproportion and altered glucose 
metabolism (Anderson et al., 2015). Alternatively, the small body size in mef2ca+/-
mef2cb-/- mutant fish arise from craniofacial defects as Mef2c in mouse and mef2ca in 
fish were found to be essential for craniofacial development (DeLaurier et al., 2014; 
Miller et al., 2007; Nichols et al., 2016; Verzi et al., 2007). Non-lethal jaw defects in 
zebrafish, seen also for some mef2ca allelic combinations (Miller et al., 2007) can lead 
to insufficient feeding and small body weight, as we found in scleraxis mutants (Kague 
et al., 2019). Finally, as fish and mouse Mef2cs express in tissues such as CNS, bone, 
smooth muscle and other cell types (Anderson et al., 2004; Arnold et al., 2007; Barbosa 
et al., 2008; Hammond and Udvadia, 2010), it is possible later defects unrelated to the 
muscle explain the growth phenotype. 
Interestingly, Mef2 genes are upregulated upon cardiac injury in zebrafish (Wang and 
Poss, 2016), which could relate to their ability to regenerate the myocardium.  




Encouragingly, our data argue that low residual Mef2c function in our single allele 
mutant combinations appears sufficient to support CM proliferation in the 3-5 dpf period.  
Recently, two studies have identified two individual MEF2C mutations in patients with 
SHF-related congenital heart disease (CHD) (Lu et al., 2018; Qiao et al., 2017), 
highlighting the importance of correct levels and function of MEF2C in human heart. 
Whether physiological regeneration and exercise tests on mef2ca+/-mef2cb-/- adult fish 
would reveal cardiac defects remains to be determined. 
 
Mef2c place in the cardiac transcriptional cascade  
How does Mef2c activity fit into the hierarchy of SHF cardiomyogenesis?  The 
downregulation of ltbp3 and up-regulation of nkx2.5 observed in mef2ca+/-mef2cb-/- 
mutants at 28 hpf precedes the defects in ventricular growth at 2 and 3 dpf.  Small 
ventricles have been reported in various zebrafish mutants and deficits such as nkx2.5-
/- (Targoff et al., 2013) and ltbp3MO (Zhou et al., 2011).  The reduction of the ltbp3 mRNA 
in mef2ca+/-mef2cb-/- mutants implies a reduction in progenitor pool size at 1 dpf.  As 
Ltbp3 is involved in CM progenitor proliferation (Nevis et al., 2013; Zhou et al., 2011), 
reduction in ltbp3 expression could further decrease CM progenitors.  Nkx2.5, on the 
other hand, is implicated in specification of CMs and is also required for ltbp3 expression 
(Colombo et al., 2018; Guner-Ataman et al., 2013; Strate et al., 2015; Targoff et al., 
2013).  Our data show that even in the presence of raised nkx2.5 mRNA and protein in 
precursor cells, ltbp3 is not activated and thus Mef2c activity is required in parallel with, 
or mediates, Nkx2.5 activity on ltbp3 expression.  This understanding, together with 
results from nkx2.5/nkx2.7 mutants showing that the Nkx2 factors are required for 
mef2cb expression (Colombo et al., 2018) places mef2cb between nkx2.5/nkx2.7 and 
ltbp3 in the genetic cascade of the SHF in zebrafish.  
 




We previously showed that in double mutant fish completely lacking Mef2c activity, 
specification of FHF CM precursors occurred correctly prior to heart tube formation and 
the bilateral heart fields were indistinguishable from sibling embryos. However, in the 
absence of Mef2c protein, differentiation markers were reduced and specified cells were 
lost. Expression of nkx2.5 was diminished when progenitors failed to differentiate (Hinits 
et al., 2012).  It is also possible that Mef2c binds to Nkx2.5 regulatory elements to allow 
Nkx2.5 recruitment and autoregulation as shown for mice and other vertebrates (Clark 
et al., 2013).  Here, we find that when Mef2c activity is low, but differentiation occurs, 
ventricular and atrial CMs respond differently; ventricular CMs upregulate nkx2.5 
expression, which may reflect a function of Nkx2.5 in maintaining ventricular identity 
(George et al., 2015; Targoff et al., 2013). Low levels of Mef2c can therfore not just 
prevent many CMs from differentiating and incorporating into the ventricle but the ones 
that do differentiate and beat may fail to mature through the effects of reduction of Mef2c 
on Nkx2.5 levels. 
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Figure 1. Ventricular myocardium expands and thickens by CM addition. (A) 
Ventricular axes were measured on confocal images of live Tg(myl7:EGFP) embryonic 
hearts at 3 and 5 dpf. Ventral half of ventricle shown. Graph shows increase in length of 
each axis. (B) Myocardial thickness increased significantly from 3 to 5 dpf. (C,D) 
Myocardial volume (C) and surface area (D) were measured by thresholding for GFP in 
scans of Tg(myl7:EGFP) embryos (see materials and methods), both increased 
significantly by 52% between 3 and 5 dpf. (E) Trabecular length increased 500% 
between 3 to 5 dpf. (F) Tg(myl7:EGFP);Tg(myl7:DsRed2-NLS) were thresholded to 
count DsRed CM nuclei. Number of ventricular CMs increased by 26% from 3 to 5 dpf, 
n = 5 and n = 4 respectively. (G,H) Confocal section through Tg(myl7:EGFP-
Has.HRAS)s883  scatter labelled with cytoplasmic mCherry (G, white arrow). Graph of 
average cell volume (H) measured from three hearts at 3 dpf (9 cells) or 5 dpf (10 cells).  
(I,J) Confocal optical sections through Tg(myl7:EGFP-Has.HRAS)s883  fish at 3 and 5 
dpf with four CM perimeter measures carried out in each optical plane. Graph (J) shows 
cell measurements from four hearts for each time point. Values in all graphs are mean 
± SEM. N for each group shown on bars. Statistics used unpaired Student’s t-test. Scale 
bars = 20 µm. 
 
Figure 2. CM addition, hypertrophy and proliferation are involved in ventricular 
growth between 3 and 5 dpf. (A) Three Optical sections of 5 dpf 
Tg(myl7:GAL4FF)hu6531;Tg(5XUAS:RFP)zf83;Tg(UAS:h2az2a-GFP)hu6851 larval heart 
immunostained for GFP (green), RFP (red) and PH3 (magenta) to reveal the sole 
PH3+nucGFP+ CM detected in this heart (arrow). Note the additional PH3+nucGFP- cells 
enclosed by the myocardial layer (arrowheads). (B) Number of PH3+ CMs/ventricle at 3 
dpf, 4 dpf and 5 dpf. Mean ± SEM. Each dot represents an animal. (C,D) 




Tg(myl7:GAL4FF)hu6531;Tg(UAS:h2az2a-GFP)hu6851 embryos were exposed to EdU 
between 4 and 5 dpf. A short confocal stack reveals EdU-labelled CMs (arrowheads, 
C), which were quantified as the fraction of EdU+ nuclei in H2A-GFP-labelled CMs in 
ventricle, atrium and whole heart (D). (E,F) Confocal images of anterior ventricle and 
OFT region of a Tg(nkx2.5:galFF);Tg(UAS:h2a-gfp);Tg(myl7:nucDsRed) larva imaged 
at 3 and 5 dpf showing an nucGFP+;nucDsRed- cell population (white bracket) adjacent 
to the OFT region (arrow) at each stage (E).  nucGFP+ cells were counted in the 
bracketed areas (F). (G,H) Confocal stacks of embryos of 3.5 (G) and 6 dpf (H) carrying 
Tg(myl7:EGFP)twu26 and Tg(–5.1myl7:DsRed2-NLS)f2. G’ and H’ show in greater detail 
the boxed OFT region. EGFP+ dsRed- cells are clearly present at 3.5 dpf indicating 
recently differentiated CMs (arrowheads), whereas by 6 dpf all cells seem to be positive 
for both EGFP and DsRed.  (I) Schematic diagram of the Kaede conversion experiment. 
(J) Confocal stacks of hearts 5 dpf embryos carrying Tg(myl7:GAL4FF)hu6531 and 
Tg(UAS:Kaede)rk8 in which Kaede was converted from green to red at 3 dpf.  
Transmitted light of the scanned area is shown in J’. Cells expressing green Kaede but 
no or little red Kaede are marked by white arrow (OFT and ventricle nearby), light blue 
arrow (AVC), and yellow arrow (ventricle apex). Note, atrial cell expressing green Kaede 
only (asterisk) was found only in this embryo. Scale bars = 50 µm, except A and E 
= 20 µm. 
 
Figure 3. Mef2c is required for the formation of the heart. (A) In situ mRNA 
hybridisation for myl7 on 1 dpf embryos from an incross of mef2ca+/-;mef2cb+/- in dorsal 
view, anterior to top, sequence genotyped retrospectively.  Images are representative 
of the majority of embryos of each genotype.  mef2ca-/-;mef2cb-/- embryos had a severe 
reduction in myl7 expression. mef2ca+/-;mef2cb-/- also showed a reduction in myl7 
expression but to a lesser extent than double homozygous mutants.  (B) Confocal stack 




of live hearts of mef2ca-/-;mef2cb-/- and its sibling on a Tg(myl7:EGFP) background. 
Double homozygous mutants continue to show a severe heart defect at 3 and 5 dpf but 
some growth in the differentiated structure is observed.  (C) Heart rate measurements 
at 1-3 dpf for genotyped embryos showing no differences in heart rate of mef2ca+/-
;mef2cb-/- embryos compared with their siblings (unpaired Student’s t-test, P> 0.05). 
Values are mean ± SEM. N for each group shown on bars. (D) Hearts of 52 hpf embryos 
from a cross of mef2ca+/-;mef2cb+/- to mef2cb-/- shown in ventral view after a double in 
situ hybridisation for nppa (blue) and myl7 (red). Sibling shown is mef2ca+/+;mef2cb+/-. 
Hearts of mef2ca+/-;mef2cb-/- are smaller and underdeveloped.  Scale bars = 50 µm. 
 
Figure 1. Mef2ca+/-;mef2cb-/- mutant embryos show reduced ventricular size 
compared to siblings. (A) Confocal images of 3 dpf (top panels) or 5 dpf hearts (bottom 
panels) from a cross of mef2ca+/-;mef2cb+/-;Tg(myl7:EGFP) to either mef2ca+/+;mef2cb+/-
;Tg(myl7:EGFP) or mef2ca+/-;mef2cb+/+;Tg(myl7:EGFP) fish. mef2ca+/-;mef2cb-/- 
embryos have a smaller heart at 3 and 5 dpf. Scale bars = 50 µm. (B,C) Volume, 
trabecular length and width were quantified for embryos from crosses in A designed to 
test Mef2ca (B) and Mef2cb (C) function. One-way ANOVA analysis followed by 
Bonferroni post hoc tests, p-values indicated on graphs. Graphs show mean ± S.E.M. 
N for each group shown on bars. 
 
Figure 5. Mef2ca+/-;mef2cb-/- mutant embryos have reduced CM and changes in 
SHF gene expression.  (A,B) Embryos from a cross of mef2ca+/-;mef2cb+/-
;Tg(myl7:EGFP) and mef2cb+/-;Tg(myl7:EGFP);Tg(myl7:nucDsRed) were fixed and 
immunostained with GFP (green) and RFP (red) antibodies at 1 dpf or imaged live at 3 
and 5 dpf and CM nuclei counted.  Confocal stacks are shown on red channel only at 1 
dpf for clarity (A). Nuclei number of mef2ca+/-;mef2cb-/- (red bars) was significantly lower 
than in siblings (blue bars) at all stages (Unpaired Student’s t-test, P-values indicated 




on graph). Values are mean ± S.E.M. N shown on bars. (C,D) Embryos from a cross of 
mef2ca+/-;mef2cb+/-;Tg(myl7:EGFP) to mef2cb+/- at 28 hpf (C) and 3 dpf (D) hybridised 
for ltbp3 mRNA (Fast Red) and myl7:EGFP detected with anti-GFP antibody. Hearts of 
mef2ca+/-;mef2cb-/- showed less differentiated myocardium (myl7:EGFP) co-expressing 
ltbp3 mRNA and ltbp3 levels outside the heart were also reduced (C), but by 3 dpf little 
difference was seen between genotypes (D). (E,F) In situ mRNA hybridisation for nkx2.5 
(blue) and myl7 (red) in embryos from a cross of mef2ca+/-;mef2cb+/- and mef2cb-/- at 28 
hpf (E, dorsal view) and 52 hpf (F, ventral view, same embryos shown in top panel for 
nkx2.5 only and in bottom panel for nkx2.5 and myl7). nkx2.5 mRNA was upregulated 
slightly at 28 hpf but was clearly upregulated throughout the ventricle and down in the 
atrium at 52 hpf, beyond the normal strong expression in AVC (white arrowhead) and 
the arterial pole (yellow arrowhead). Dotted line (bottom panel, F) marks chambers. (G) 
Confocal stack of immunodetection of Nkx2.5 and GFP (myl7:EGFP) of hearts of 
mef2ca+/-;mef2cb+/- and sibling at 28 hpf in dorsal view showing Nkx2.5 upregulation in 
the ventricular region of the heart tube (white arrow) and in the arterial pole (yellow 
arrowhead).  Scale bars = 50 µm. 
 
Figure 6. Mef2ca+/-mef2cb-/- adults are viable but small.  (A) Weight and standard 
length (SL) of genotyped three to four month old adult fish were measured and standard 
weight (K) calculated. Mef2ca+/-;mef2cb-/- mutant adults had a significantly lower BW and 
SL compared with their siblings. Graphs show mean ± S.E.M. for pooled data from 2 
lays. N for each group shown on bars.  One-way ANOVA was performed followed by 
Dunnett test for multiple comparison. (B-D) Mef2ca+/-;mef2cb-/-, mef2cb-/-  and siblings at 
4 months of age were measured and their heart dissected and imaged (B). Ventricle 
length (VL) was measured from images from the centre of the bulbous to the apex of 
the heart (diagram in C). Graph shows mean ± S.E.M. N for each group shown on bars.  




VL was plotted vs. SL (D). Note that points for mef2ca+/-mef2cb-/- mutants fall below the 
linear regression line. Scale bars = 1 mm.  




Supplementary Figure S1. Kaede conversion at 3 dpf. 
Confocal stacks of hearts of 3 dpf embryos carrying Tg(myl7:gal4FF)hu6531 and 
Tg(UAS:Kaede)rk8 before (A) and after (B) Kaede-green was converted to Kaede-red.  
Transmitted light of the scanned area is shown in C.A, atrium, V, ventricle. Scale bars = 
50 µm. 
Supplementary Figure S2. Incrosses of mef2ca+/-;mef2cb+/- give rise to an array of 
heart phenotypes. (A-C). In situ mRNA hybridisation for cdh5 and myl7 (A) at 22 ss, 
bmp4 (B), vmhc and myl7 (C) at 24 hpf in hearts of zebrafish embryos shown in a dorsal 
view, anterior to top. Heavy loss of myocardial differentiation markers in the heart is 
seen in a fraction likely to be mef2ca-/-;mef2cb-/- mutants (right panels), whereas a larger 
fraction show a milder reduction (middle panels) compared with normal looking hearts 
(left panels). Numbers of embryos (ungenotyped) are indicated on panels. (D,E) 
Confocal stacks of hearts from 3 dpf embryos from a cross between Tg(myl7:EGFP); 
mef2ca+/-;mef2cb+/- and mef2cb-/- stained for GFP antibody (green) and MyHC (red) 
showing a smaller, mis-shaped ventricle in  mef2ca+/-;mef2cb-/- , with undeveloped OFT 
(white arrow). Graph (E) shows average ventricle volumes across the various 
genotypes. mef2ca+/-;mef2cb-/- volume is significantly lower than that 
mef2ca+/+;mef2cb+/- . Data shown as mean +/- SEM. Statistics: one-way ANOVA 
followed by Tukey’s multiple comparisons test. Scale bars = 100 µm, except in D = 
50 µm. 
Supplementary Figure S3. Nkx2.5 protein and reporter expression. (A) Confocal 
stacks of 3 dpf wild type embryos stained for Nkx2.5 antibody (red) and MyHC (A4.1025, 
green). (B,C). Confocal stack of embryos from a cross of mef2ca+/-;mef2cb+/-
;Tg(nkx2.5BACgalFF);Tg(UAS:h2a-gfp) and mef2cb-/- genotyped and immunostained 
for GFP (green), and MyHC (A4.1025, red). GFP+ nuclei (nkx2.5+, arrowheads) outside 
the differentiated ventricle, near the OFT were counted using the sternohyoides 




muscle inner edge as a border, and shown in C. Scale bars = 50 µm. A, atrium, V, 
ventricle, sternohyoides (sh). 
Supplementary Figure S4. Transcription factor analysis in ltbp3 and mef2cb 
sequences. A. Sequence of 1.5 Kb of proximal promoter of ltbp3 is shown with Mef2c 
and Nkx2.5 binding sites according to analysis using TRANSFAC (Wingender, 2008) B. 
Comparative analysis of mef2cb locus using Evolutionary Conserved Region (ECR) 
browser (http://www.dcode.org) (Ovcharenko et al., 2004) and rVISTA 2.0 (Loots and 
Ovcharenko, 2004) found two ECRs, labelled A and B, that contain a conserved 
potential Nkx2.5 binding site, highlighted in an alignment with the mouse Mef2c and 
human MEF2C sequences. Zebrafish ECR A has 71% identity with both human and 
mouse, whereas ECR B has 75% and 70% identity with human and mouse, respectively. 
Colour codes for peaks: blue: coding exons, yellow: UTRs, salmon: intronic regions, red: 
intergenic regions, pink line: ECRs. 
Supplementary Figure S5. Expression of mef2s at 3 dpf. (A-C). Wholemount in situ 
mRNA hybridisation for myl7 (in red) and mef2ca (A), mef2cb (B) and mef2aa (C) at 72 
hpf, shown in ventral view (top panels) and lateral view (bottom panels). Only mef2aa 
mRNA is strongly expressed in the heart at this time, especially the ventricle (arrows) 













Supplementary Figure S1. Kaede conversion at 3 dpf. 
Confocal stacks of hearts of 3 dpf embryos carrying Tg(myl7:gal4FF)hu6531 and 
Tg(UAS:Kaede)rk8 before (A) and after (B) Kaede-green was converted to Kaede-red.  




Supplementary Figure S2. Incrosses of mef2ca+/-;mef2cb+/- give rise to an array of 
heart phenotypes. (A-C). In situ mRNA hybridisation for cdh5 and myl7 (A) at 22 ss, bmp4 
(B), vmhc and myl7 (C) at 24 hpf in hearts of zebrafish embryos shown in a dorsal view, 
anterior to top. Heavy loss of myocardial differentiation markers in the heart is seen in a 
fraction likely to be mef2ca-/-;mef2cb-/- mutants (right panels), whereas a larger fraction show 
a milder reduction (middle panels) compared with normal looking hearts (left panels). 
Numbers of embryos (ungenotyped) are indicated on panels. (D,E) Confocal stacks of hearts 
from 3 dpf embryos from a cross between Tg(myl7:EGFP); mef2ca+/-;mef2cb+/- and mef2cb-/- 
stained for GFP antibody (green) and MyHC (red) showing a smaller, mis-shaped ventricle in  
mef2ca+/-;mef2cb-/- , with undeveloped OFT (white arrow). Graph (E) shows average ventricle 
volumes across the various genotypes. mef2ca+/-;mef2cb-/- volume is significantly lower than 
that mef2ca+/+;mef2cb+/- . Data shown as mean +/- SEM. Statistics: one-way ANOVA followed 
by Tukey’s multiple comparisons test. Scale bars = 100 µm, except in D = 50 µm. 
 
Supplementary Figure S3. Nkx2.5 protein and reporter expression. (A) Confocal stacks 
of 3 dpf wild type embryos stained for Nkx2.5 antibody (red) and MyHC (A4.1025, green). 
(B,C). Confocal stack of embryos from a cross of mef2ca+/-;mef2cb+/-
;Tg(nkx2.5BACgalFF);Tg(UAS:h2a-gfp) and mef2cb-/- genotyped and immunostained for 
GFP (green), and MyHC (A4.1025, red). GFP+ nuclei (nkx2.5+, arrowheads) outside the 
differentiated ventricle, near the OFT were counted using the sternohyoides muscle inner 
edge as a border, and shown in C. Scale bars = 50 µm. A, atrium, V, ventricle, sternohyoides 
(sh). 
Supplementary Figure S4. Transcription factor analysis in ltbp3 and mef2cb 
sequences. A. Sequence of 1.5 Kb of proximal promoter of ltbp3 is shown with Mef2c and 
Nkx2.5 binding sites according to analysis using TRANSFAC (Wingender, 2008) B. 
Comparative analysis of mef2cb locus using Evolutionary Conserved Region (ECR) browser 
(http://www.dcode.org) (Ovcharenko et al., 2004) and rVISTA 2.0 (Loots and Ovcharenko, 
2004) found two ECRs, labelled A and B, that contain a conserved potential Nkx2.5 binding 
site, highlighted in an alignment with the mouse Mef2c and human MEF2C sequences. 
Zebrafish ECR A has 71% identity with both human and mouse, whereas ECR B has 75% 
and 70% identity with human and mouse, respectively. Colour codes for peaks: blue: coding 
exons, yellow: UTRs, salmon: intronic regions, red: intergenic regions, pink line: ECRs. 
 
Supplementary Figure S5. Expression of mef2s at 3 dpf. (A-C). Wholemount in situ 
mRNA hybridisation for myl7 (in red) and mef2ca (A), mef2cb (B) and mef2aa (C) at 72 hpf, 
shown in ventral view (top panels) and lateral view (bottom panels). Only mef2aa mRNA is 
strongly expressed in the heart at this time, especially the ventricle (arrows) and the OFT 
(white arrowhead). A, atrium, V, ventricle. Scale bars = 100 µm. 
 
 
 
